Co-Authors
This is a "connection" page, showing publications co-authored by KIMBERLY BIRTCHER and MICHAEL JOHNSON.
Connection Strength
0.428
-
Patterns of Lipid Lowering Therapy Use Among Older Adults in a Managed Care Advantage Plan in the United States. J Pharm Pract. 2024 Feb; 37(1):123-131.
Score: 0.207
-
Effect of initial combination therapy vs. step-therapy on adherence and persistence in drug na?ve type 2 diabetes patients. J Diabetes Complications. 2025 May 14; 39(9):109080.
Score: 0.062
-
Real-world treatment patterns in drug na?ve type 2 diabetes population: Initial combination therapy vs. sequential step-therapy. J Am Pharm Assoc (2003). 2025 Jan-Feb; 65(1):102295.
Score: 0.060
-
Evaluating adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments and intermediate outcomes among elderly patients using marginal structural modeling. Pharmacotherapy. 2022 07; 42(7):518-528.
Score: 0.050
-
Adherence to concomitant diabetes, hypertension, and hyperlipidemia treatments among older patients. J Am Pharm Assoc (2003). 2022 Jul-Aug; 62(4):1351-1358.
Score: 0.050